期刊文献+

关于创伤脓毒症免疫调理策略的思考 被引量:2

Consideration about immunotherapy for sepsis following trauma
下载PDF
导出
摘要 目的有关创伤与免疫的研究始于1970年,经历了现象描述的起始阶段,创伤免疫抑制及其机制的初级阶段,创伤后免疫功能紊乱的发展阶段,以及当前的创伤后免疫调理防治脓毒症的第四阶段。对于脓毒症的免疫调理策略应把握"堵"、"疏"兼顾的原则,既对脓毒反应的启动采取拮抗的防治措施,又着眼于提高机体抵抗力,特别是提高机体的应激反应能力;早期以"堵"为主,晚期以"疏"为主,同时注重动态调整机体最佳的应激反应状态。 There were four stages in the establishment,development and evolvement of the research history about trauma and immunity which began in 1970s,namely the initiatory stage describing phenomena,primary stage focusing at mechanism of immunosuppression,developing stage proposing immune dysfunction notion,and the fourth stage,the immunomodulating stage.Three key points should be paid more attention during the immunomodulation of sepsis.Firstly,block and release,we should not only block the initiators or triggers of sepsis,but also release and promote the metabolization of inflammatory mediators and dangerous signal produced during sepsis,especially to improve the ability in stress response.Secondly,predominantly block at early stage and release at late stage.Thirdly,adjust the immune status dynamically for guidance and regulation of sepsis treatment.
作者 李磊
出处 《创伤外科杂志》 2010年第4期289-292,共4页 Journal of Traumatic Surgery
关键词 脓毒症 创伤 免疫 sepsis trauma immunology
  • 相关文献

参考文献10

  • 1Akira S,Uematsu S,Takeuchi O.Pathogen recognition and innate immunity[J].Cell,2006,124(4):783-801.
  • 2Seong SY,Matzinger P.Hydrophobicity:an ancient damage-associated molecular pattern that initiates innate immune responses[J].Nature Reviews Immunology,2004,4(6):469-478.
  • 3Ye Z,Ting JP.NLR,the nucleotide-binding domain leucine-rich repeat containing gene family[J].Curr Opin Immunol,2008,20(1):3-9.
  • 4Ting JP,Lovering RC,Alnemri ES,et al.The NLR gene family:a standard nomenclature[J].Immunity,2008,28(3):285-287.
  • 5Martinon F,Mayor A,Tschopp J.The inflammasomes:guardians of the body[J].Annu Rev Immunol,2009,27:229-265.
  • 6Kawai T,Akira S.The roles of TLRs,RLRs and NLR in pathogen recognition[J].Int Immunol,2009,21(4):317-337.
  • 7Lamkanfi M,Kanneganti TD.Nlrp3:an immune sensor of cellular stress and infection[J].Int J Biochem Cell Biol,2010,42(6):792-795.
  • 8O'Brien JM Jr,Ali NA,Abraham E.Year in review 2007:Critical Care-multiple organ failure and sepsis[J].Crit Care,2008,12(5):228-233.
  • 9李磊,王正国.炎症组学——应运而生的新概念[J].中华创伤杂志,2010,26(1):3-5. 被引量:6
  • 10Baillie JK.Activated protein C:controversy and hope in the treatment of sepsis[J].Curr Opin Invest Drugs,2007,8(11):933-938.

二级参考文献11

  • 1Matzinger P. The danger model: a renewed sense of self. Science, 2002, 296(5566) :301 -305.
  • 2Medzhitov R, Janeway CA Jr. Innate immune recognition and control of adaptive immune response. Semin Immunol, 1998, 10 (5) : 351 - 353.
  • 3Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell, 2006, 124(4) :783 -801.
  • 4Seong SY, Matzinger P. Hydrophobicity : An ancient damage - associated molecular pattern that initiates innate immune responses. Nat Rev Immunol, 2004, 4(6) :469 -478.
  • 5Ye Z, Ting JP. NLR, the nucleotide - binding domain leucine - rich repeat containing gene family. Curr Opin Immunol, 2008, 20 (1):3-9.
  • 6Ting JP, Lovering RC, Alnemri ES, et al. The NLR gene family : A standard nomenclature. Immunity, 2008, 28(3) :285 - 287.
  • 7Mrtion F, Burns K, Tschopp J. The inflammasome: a molecular plaffrorm triggering activation of inflammatory caspases and processing of proIL - beta. Mol Cell, 2002, 10(2) :417 - 426.
  • 8Martinon F, Mayor A, Tschopp J. The inflammasomes Guardians of the body. Ann Rev Immunol, 2009, 27:229 -265.
  • 9Suzanne L. Cassela SL, Jolyb S, et al. The NLRP3 inflammasome : A sensor of immune danger signals. Seminars in Immunology 2009 ( online doi : 10. 1016/j. smim. 2009.05. 002 ).
  • 10Geijtenbeek TB, Gringhuis SI. Signalling through C - type lectin receptors shaping immune responses. Nat Rev Immunol, 2009, 9 (7) :465 -479.

共引文献5

同被引文献27

引证文献2

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部